Viewing StudyNCT00358683



Ignite Creation Date: 2024-05-05 @ 4:57 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00358683
Status: WITHDRAWN
Last Update Posted: 2012-05-28
First Post: 2006-07-28

Brief Title: A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohns Disease
Sponsor: UCB Pharma
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Crohns Disease
Keywords:
Name View
Greek population View
certolizunab pegol View
long term safety follow-up View
Chrohns disease View
infliximab failures patients View